Table of Content

1 Introduction 5
1.1 Industry Definition and Research Scope 5
1.1.1 Industry Definition 5
1.1.2 Research Scope 6
1.2 Research Methodology 8
1.2.1 Overview of Market Research Methodology 8
1.2.2 Market Assumption 9
1.2.3 Secondary Data 9
1.2.4 Primary Data 9
1.2.5 Data Filtration and Model Design 10
1.2.6 Market Size/Share Estimation 11
1.2.7 Research Limitations 12
1.3 Executive Summary 13

2 Market Overview and Dynamics 15
2.1 Market Size and Forecast 15
2.2 Major Growth Drivers 16
2.3 Market Restraints and Challenges 19
2.4 Emerging Opportunities and Market Trends 22
2.5 Porter’s Fiver Forces Analysis 25

3 Segmentation of North America Market by Product Type 29
3.1 Market Overview by Product Type 29
3.2 Human Insulin Drugs 31
3.3 Human Insulin Delivery Devices 32

4 Segmentation of North America Human Insulin Drugs Market by Drug Product 33
4.1 Market Overview by Drug Product 33
4.2 Modern Human Insulin 35
4.2.1 Modern Human Insulin by Type 37
4.2.2 Modern Human Insulin by Brand 41
4.3 Traditional Human Insulin 48
4.3.1 Traditional Human Insulin by Type 50
4.3.2 Traditional Human Insulin by Brand 53

5 Segmentation of North America Human Insulin Delivery Devices Market by Device Product 56
5.1 Market Overview by Product 56
5.2 Syringes 58
5.3 Pens 59
5.4 Pumps 60
5.5 Other Devices 62

6 Segmentation of North America Market by Application 63
6.1 Market Overview by Application 63
6.2 Type 1 Diabetes 65
6.3 Type 2 Diabetes 66
6.4 Gestational Diabetes and Prediabetes 67

7 Segmentation of North America Market by Distribution Channel 68
7.1 Market Overview by Distribution Channel 68
7.2 Hospital Pharmacies 70
7.3 Retail Pharmacies 71
7.4 Online Pharmacies 72

8 North America Market 2019-2026 by Country 73
8.1 Overview of North America Market 73
8.2 U.S. Market 76
8.3 Canadian Market 80

9 Competitive Landscape 82
9.1 Overview of Key Vendors 82
9.2 New Product Launch, Partnership, Investment, and M&A 86
9.3 Company Profiles 88
Astra Zeneca PLC 88
Biocon 90
Eli Lilly 91
Exir 92
Julphar 93
Novo Nordisk AS 94
Pfizer 95
Sanofi Aventis 96
Sedico 97
Wockhardt 98

10 Investing in North America Market: Risk Assessment and Management 99
10.1 Risk Evaluation of North America Market 99
10.2 Critical Success Factors (CSFs) 102
Related Reports and Products 105



List of Figures


Figure 1. Research Method Flow Chart 8
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 11
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2026 13
Figure 4. North America Human Insulin Market, 2019-2026, $ mn 15
Figure 5. Primary Drivers and Impact Factors of North America Human Insulin Market 16
Figure 6. Primary Restraints and Impact Factors of North America Human Insulin Market 19
Figure 7. Porter’s Fiver Forces Analysis of North America Human Insulin Market 25
Figure 8. Breakdown of North America Human Insulin Market by Product Type, 2019-2026, % of Revenue 29
Figure 9. Contribution to North America 2020-2026 Cumulative Revenue by Product Type, Value ($ mn) and Share (%) 30
Figure 10. North America Human Insulin Market: Human Insulin Drugs, 2019-2026, $ mn 31
Figure 11. North America Human Insulin Market: Human Insulin Delivery Devices, 2019-2026, $ mn 32
Figure 12. Breakdown of North America Human Insulin Drugs Market by Product, 2019-2026, % of Revenue 33
Figure 13. Contribution to North America Human Insulin Drugs Cumulative Revenue by Product, 2020-2026, Value ($ mn) and Share (%) 34
Figure 14. North America Human Insulin Market: Modern Human Insulin, 2019-2026, $ mn 35
Figure 15. North America Modern Human Insulin Market: Long-acting, 2019-2026, $ mn 37
Figure 16. North America Modern Human Insulin Market: Rapid- acting, 2019-2026, $ mn 38
Figure 17. North America Modern Human Insulin Market: Premixed, 2019-2026, $ mn 40
Figure 18. North America Modern Human Insulin Market: Lantus, 2019-2026, $ mn 41
Figure 19. North America Modern Human Insulin Market: Apidra, 2019-2026, $ mn 42
Figure 20. North America Modern Human Insulin Market: Levemir, 2019-2026, $ mn 43
Figure 21. North America Modern Human Insulin Market: NovoRapid/ NovoLog, 2019-2026, $ mn 44
Figure 22. North America Modern Human Insulin Market: Novomix, 2019-2026, $ mn 45
Figure 23. North America Modern Human Insulin Market: Humalog, 2019-2026, $ mn 46
Figure 24. North America Modern Human Insulin Market: Other Brands, 2019-2026, $ mn 47
Figure 25. North America Human Insulin Market: Traditional Human Insulin, 2019-2026, $ mn 48
Figure 26. North America Traditional Human Insulin Market: Short-acting, 2019-2026, $ mn 50
Figure 27. North America Traditional Human Insulin Market: Intermediate & Rapid-acting, 2019-2026, $ mn 51
Figure 28. North America Traditional Human Insulin Market: Premixed, 2019-2026, $ mn 52
Figure 29. North America Traditional Human Insulin Market: Humulin, 2019-2026, $ mn 53
Figure 30. North America Traditional Human Insulin Market: Insuman, 2019-2026, $ mn 54
Figure 31. North America Traditional Human Insulin Market: Novolin/Actrapid/Insulatard, 2019-2026, $ mn 55
Figure 32. Breakdown of North America Human Insulin Delivery Devices Market by Product, 2019-2026, % of Revenue 56
Figure 33. Contribution to North America Human Insulin Delivery Devices Cumulative Revenue by Product, 2020-2026, Value ($ mn) and Share (%) 57
Figure 34. North America Human Insulin Delivery Devices Market: Syringes, 2019-2026, $ mn 58
Figure 35. North America Human Insulin Delivery Devices Market: Pens, 2019-2026, $ mn 59
Figure 36. North America Human Insulin Delivery Devices Market: Pumps, 2019-2026, $ mn 60
Figure 37. North America Human Insulin Delivery Devices Market: Other Devices, 2019-2026, $ mn 62
Figure 38. Breakdown of North America Human Insulin Market by Application, 2019-2026, % of Revenue 63
Figure 39. Contribution to North America 2020-2026 Cumulative Revenue by Application, Value ($ mn) and Share (%) 64
Figure 40. North America Human Insulin Market: Type 1 Diabetes, 2019-2026, $ mn 65
Figure 41. North America Human Insulin Market: Type 2 Diabetes, 2019-2026, $ mn 66
Figure 42. North America Human Insulin Market: Gestational Diabetes and Prediabetes, 2019-2026, $ mn 67
Figure 43. Breakdown of North America Human Insulin Market by Distribution Channel, 2019-2026, % of Revenue 68
Figure 44. Contribution to North America 2020-2026 Cumulative Revenue by Distribution Channel, Value ($ mn) and Share (%) 69
Figure 45. North America Human Insulin Market: Hospital Pharmacies, 2019-2026, $ mn 70
Figure 46. North America Human Insulin Market: Retail Pharmacies, 2019-2026, $ mn 71
Figure 47. North America Human Insulin Market: Online Pharmacies, 2019-2026, $ mn 72
Figure 48. Breakdown of North America Human Insulin Market by Country, 2019 and 2026, % of Revenue 74
Figure 49. Contribution to North America 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%) 75
Figure 50. U.S. Human Insulin Market, 2019-2026, $ mn 77
Figure 51. Canada Human Insulin Market, 2019-2026, $ mn 80
Figure 52. Growth Stage of North America Human Insulin Industry over the Forecast Period 82


List of Tables


Table 1. Snapshot of North America Human Insulin Market, 2019-2026 14
Table 2. Main Product Trends and Market Opportunities in North America Human Insulin Market 22
Table 3. North America Human Insulin Market by Product Type, 2019-2026, $ mn 29
Table 4. North America Human Insulin Drugs Market by Product, 2019-2026, $ mn 33
Table 5. North America Human Insulin Drugs Market: Modern Human Insulin by Type, 2019-2026, $ mn 36
Table 6. North America Human Insulin Drugs Market: Modern Human Insulin by Brand, 2019-2026, $ mn 36
Table 7. North America Human Insulin Drugs Market: Traditional Human Insulin by Type, 2019-2026, $ mn 49
Table 8. North America Human Insulin Drugs Market: Traditional Human Insulin by Brand, 2019-2026, $ mn 49
Table 9. North America Human Insulin Delivery Devices Market by Product, 2019-2026, $ mn 56
Table 10. North America Human Insulin Delivery Devices Market: Pens by Product, 2019-2026, $ mn 59
Table 11. North America Human Insulin Market by Application, 2019-2026, $ mn 63
Table 12. North America Human Insulin Market by Distribution Channel, 2019-2026, $ mn 68
Table 13. North America Human Insulin Market by Country, 2019-2026, $ mn 74
Table 14. U.S. Human Insulin Market by Product Type, 2019-2026, $ mn 78
Table 15. U.S. Human Insulin Market by Application, 2019-2026, $ mn 78
Table 16. U.S. Human Insulin Market by Distribution Channel, 2019-2026, $ mn 78
Table 17. Canada Human Insulin Market by Product Type, 2019-2026, $ mn 81
Table 18. Canada Human Insulin Market by Application, 2019-2026, $ mn 81
Table 19. Canada Human Insulin Market by Distribution Channel, 2019-2026, $ mn 81
Table 20. North America Human Insulin Market by Key Vendor, 2019, $ mn 84
Table 21. Astra Zeneca PLC: Company Snapshot 88
Table 22. Astra Zeneca PLC: Business Segmentation 88
Table 23. Astra Zeneca PLC: Product Portfolio 89
Table 24. Astra Zeneca PLC: Revenue, 2016-2018, $ mn 89
Table 25. Astra Zeneca PLC: Recent Developments 89
Table 26. Risk Evaluation for Investing in North America Market, 2019-2026 100
Table 27. Critical Success Factors and Key Takeaways 103